Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
12.86
-0.03 (-0.23%)
Jul 3, 2025, 4:00 PM EDT
-9.82%
Fund Assets 861.68M
Expense Ratio 1.17%
Min. Investment $1,000
Turnover 15.00%
Dividend (ttm) 0.62
Dividend Yield 4.59%
Dividend Growth 92.11%
Payout Frequency Annual
Ex-Dividend Date Dec 5, 2024
Previous Close 12.89
YTD Return -0.62%
1-Year Return -5.70%
5-Year Return 32.10%
52-Week Low 12.15
52-Week High 15.66
Beta (5Y) n/a
Holdings 50
Inception Date Jul 26, 1985

About ETHSX

Eaton Vance Worldwide Health Sciences Fund Class A is a diversified mutual fund focused on delivering long-term capital growth by investing in a global portfolio of health sciences companies. As a specialized fund, it targets equities within the healthcare sector, spanning industries such as pharmaceuticals, biotechnology, medical devices, health service providers, and hospital operators. The portfolio is structured to provide exposure to both U.S. and international healthcare companies, with significant holdings in industry leaders like Eli Lilly, Novo Nordisk, and UnitedHealth Group. This fund offers investors the opportunity to participate in the growth and innovation of the global health sciences sector, which is influenced by demographic trends, technological advancements, and ongoing medical research. Managed with a large growth investment style, it is suited for those interested in sector-specific strategies. The fund's performance is benchmarked against the MSCI World Health Care Index, reflecting its commitment to mirroring global healthcare trends. As of its latest reporting, the fund managed net assets nearing $1 billion and maintained an expense ratio around 1.17%, emphasizing both scale and sector expertise.

Fund Family Eaton Vance
Category Health
Stock Exchange NASDAQ
Ticker Symbol ETHSX
Share Class Class A
Index MSCI World/Health Care NR

Performance

ETHSX had a total return of -5.70% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.77%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
EIHSX Class I 0.92%
ERHSX Class R 1.42%
ECHSX Class C 1.92%

Top 10 Holdings

49.34% of assets
Name Symbol Weight
Eli Lilly and Company LLY 11.52%
AbbVie Inc. ABBV 5.66%
AstraZeneca PLC AZN 5.05%
Abbott Laboratories ABT 4.65%
Roche Holding AG ROG 4.61%
Novo Nordisk A/S NOVO.B 4.18%
UnitedHealth Group Incorporated UNH 3.96%
Johnson & Johnson JNJ 3.38%
Zoetis Inc. ZTS 3.18%
Intuitive Surgical, Inc. ISRG 3.14%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 5, 2024 $0.623 Dec 6, 2024
Dec 7, 2023 $0.3243 Dec 8, 2023
Dec 8, 2022 $0.5623 Dec 9, 2022
Dec 9, 2021 $1.2056 Dec 10, 2021
Dec 10, 2020 $0.9548 Dec 11, 2020
Dec 3, 2019 $0.6671 Dec 4, 2019
Full Dividend History